<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001855608</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001743881</issuerCik>
            <issuerName>BRIDGEBIO PHARMA, INC.</issuerName>
            <secFileNumber>001-38959</secFileNumber>
            <issuerAddress>
                <ns2:street1>3160 Porter Drive</ns2:street1>
                <ns2:street2>Suite 250</ns2:street2>
                <ns2:city>Palo Alto</ns2:city>
                <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                <ns2:zipCode>94304</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>(650) 391-9740</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>HANNAH A VALANTINE</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>38th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>2915</noOfUnitsSold>
            <aggregateMarketValue>110682.55</aggregateMarketValue>
            <noOfUnitsOutstanding>173967052</noOfUnitsOutstanding>
            <approxSaleDate>01/16/2024</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>COMMON</securitiesClassTitle>
            <acquiredDate>01/16/2024</acquiredDate>
            <natureOfAcquisitionTransaction>Stock Option Exercise</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>2915</amountOfSecuritiesAcquired>
            <paymentDate>01/16/2024</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>HANNAH A VALANTINE</name>
                <address>
                    <ns2:street1>3160 Porter Drive</ns2:street1>
                    <ns2:street2>Suite 250</ns2:street2>
                    <ns2:city>Palo Alto</ns2:city>
                    <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                    <ns2:zipCode>94304</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>12/15/2023</saleDate>
            <amountOfSecuritiesSold>2915</amountOfSecuritiesSold>
            <grossProceeds>105289.80</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>HANNAH A VALANTINE</name>
                <address>
                    <ns2:street1>3160 Porter Drive</ns2:street1>
                    <ns2:street2>Suite 250</ns2:street2>
                    <ns2:city>Palo Alto</ns2:city>
                    <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                    <ns2:zipCode>94304</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>11/15/2023</saleDate>
            <amountOfSecuritiesSold>2915</amountOfSecuritiesSold>
            <grossProceeds>87450.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>01/16/2024</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>08/16/2023</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Hannah A Valantine</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4869}]
144
0001855608
XXXXXXXX
LIVE
0001743881
BRIDGEBIO PHARMA, INC.
001-38959
3160 Porter Drive
Suite 250
Palo Alto
CA
94304
(650) 391-9740
HANNAH A VALANTINE
Director
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
38th Floor
New York
NY
10004
2915
110682.55
173967052
01/16/2024
NASDAQ
COMMON
01/16/2024
Stock Option Exercise
ISSUER
N
2915
01/16/2024
Cash
N
HANNAH A VALANTINE
3160 Porter Drive
Suite 250
Palo Alto
CA
94304
Common
12/15/2023
2915
105289.80
HANNAH A VALANTINE
3160 Porter Drive
Suite 250
Palo Alto
CA
94304
Common
11/15/2023
2915
87450.00
01/16/2024
08/16/2023
/s/ Hannah A Valantine